Glabellar Lines Only
Research payments
$390,455
Through program year 2020, $390,455 in research payments was reported against Glabellar Lines Only, across 74 payments, paid by Allergan Inc..
- Paid by
- Allergan Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $19,702 | 40 |
| 2019 | Research | $370,753 | 34 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Lisa Donofrio New Haven, CT Named on 11 payments
- Brenda Latowsky Scottsdale, AZ Named on 11 payments
- Adnan Nasir Raleigh, NC Named on 9 payments
- John Tu Rochester, NY Named on 8 payments
- MacRene Alexiades-Armenakas New York, NY Named on 8 payments
- Jennifer Nash Westerville, OH Named on 8 payments
- Daniel Friedmann Austin, TX Named on 7 payments
- Melanie Palm Solana Beach, CA Named on 7 payments
- Susan Weinkle Bradenton, FL Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.